We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+8.11%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$20.6B
AUM Growth
+$1.37B
(+7.1%)
Cap. Flow
-$6.1B
Cap. Flow
% of AUM
-29.59%
Top 10 Holdings %
Top 10 Hldgs %
22.72%
Holding
1,035
New
97
Increased
87
Reduced
313
Closed
112
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$63.7M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$52.7M |
| 3 |
HES
Hess
HES
|
+$42.5M |
| 4 |
SOVO
Sovos Brands, Inc. Common Stock
SOVO
|
+$35.1M |
| 5 |
AMED
Amedisys
AMED
|
+$22.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AESC
The AES Corporation
AESC
|
+$45.2M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$39.1M |
| 3 |
Mercado Libre
MELI
|
+$39M |
| 4 |
DEN
Denbury Inc.
DEN
|
+$26M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$25.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.31% |
| 2 | Healthcare | 8.45% |
| 3 | Financials | 7.73% |
| 4 | Consumer Discretionary | 7.1% |
| 5 | Communication Services | 5.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CERE
201
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $12.9M | 0.06% |
+305,303
| New | +$8.77M |
|
202
Colgate-Palmolive
CL
$75.1B
| $12.8M | 0.06% |
160,837
-2,101
| -1% | -$158K |
|
203
CMS Energy
CMS
$23.4B
| $12.8M | 0.06% |
220,691
+78,217
| +55% | +$4.37M |
|
204
Dollar Tree
DLTR
$24.5B
| $12.7M | 0.06% |
89,059
-94,271
| -51% | -$11.2M |
|
205
DuPont de Nemours
DD
$19.2B
| $12.6M | 0.06% |
130,492
-1,704
| -1% | -$155K |
|
206
General Dynamics
GD
$106B
| $12.4M | 0.06% |
47,710
-623
| -1% | -$152K |
|
207
American Electric Power
AEP
$73.3B
| $12.3M | 0.06% |
151,474
-1,978
| -1% | -$154K |
|
208
Skyworks Solutions
SWKS
$9.77B
| $12.3M | 0.06% |
108,981
-1,423
| -1% | -$139K |
|
209
Hyatt Hotels
H
$17.7B
| $12.1M | 0.06% |
93,000
-1,000
| -1% | -$113K |
|
210
CALL
Amazon
AMZN
$2.48T
| $12M | 0.06% |
94,500
-344,500
| -78% | -$48.3M |
|
211
Paychex
PAYX
$42.4B
| $12M | 0.06% |
100,750
-1,316
| -1% | -$156K |
|
212
Teradyne
TER
$49.2B
| $11.9M | 0.06% |
109,871
-1,435
| -1% | -$136K |
|
213
Autodesk
ADSK
$51B
| $11.8M | 0.06% |
48,466
-633
| -1% | -$137K |
|
214
Vulcan Materials
VMC
$37.3B
| $11.8M | 0.06% |
51,887
+14,425
| +39% | +$3.06M |
|
215
Kimberly-Clark
KMB
$37.8B
| $11.7M | 0.06% |
96,640
-1,262
| -1% | -$153K |
|
216
Archer Daniels Midland
ADM
$40.3B
| $11.7M | 0.06% |
162,316
-2,120
| -1% | -$155K |
|
217
Equinix
EQIX
$103B
| $11.6M | 0.06% |
14,460
-188
| -1% | -$144K |
|
218
Regeneron Pharmaceuticals
REGN
$72B
| $11.6M | 0.06% |
13,211
-173
| -1% | -$142K |
|
219
Welltower
WELL
$171B
| $11.5M | 0.06% |
127,321
-1,663
| -1% | -$144K |
|
220
General Mills
GIS
$20.2B
| $11.5M | 0.06% |
175,922
-2,299
| -1% | -$148K |
|
221
Elevance Health
ELV
$82.6B
| $11.3M | 0.06% |
24,028
+156
| +0.7% | +$72.1K |
|
222
Aflac
AFL
$65.8B
| $11.3M | 0.05% |
136,821
-1,787
| -1% | -$144K |
|
223
Zions Bancorporation
ZION
$10.2B
| $11.3M | 0.05% |
256,984
-3,072
| -1% | -$111K |
|
224
Labcorp
LH
$25.5B
| $11.1M | 0.05% |
48,748
-637
| -1% | -$134K |
|
225
Digital Realty Trust
DLR
$72.3B
| $11M | 0.05% |
81,761
-1,068
| -1% | -$138K |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q4 2023 Portfolio in Review
As of Q4 2023, Calamos Advisors held 1,035 positions worth $20.6B, up 7.1% from $19.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Calamos Advisors withdrew a net $6.1B in Q4 2023, closing 112 positions and reducing 313 holdings. Its most notable exit was The AES Corporation, an estimated $45.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Calamos Advisors opened a new position in Amedisys worth $23M.
- Calamos Advisors's largest Q4 2023 buy was Amedisys: 242,110 shares worth $23M.
- Calamos Advisors added most to Tesla in Q4 2023, an estimated $63.7M increase.
- Calamos Advisors's biggest Q4 2023 reduction was Mercado Libre, cutting an estimated $39M.
- Calamos Advisors fully exited The AES Corporation in Q4 2023, selling an estimated $45.2M.
- Calamos Advisors's ten largest holdings make up 23% of its $20.6B portfolio in Q4 2023.
- Calamos Advisors opened 97 new positions and closed 112 in Q4 2023.
- Calamos Advisors's portfolio value rose 7.1% quarter-over-quarter to $20.6B.
Based on Calamos Advisors's 13F filing for Q4 2023, filed 31 Jan 2024.